Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy.

Area of Science:

• Pharmacology
• Virology
• Toxicology

Background:

• Nucleoside reverse transcriptase inhibitors (NRTIs) are foundational in antiretroviral therapy for HIV/AIDS.
• Significant clinical progress in AIDS treatment has been achieved through the use of NRTIs.
• However, NRTIs are associated with predictable and unavoidable side effects.

Purpose of the Study:

• To highlight the principal toxicity of NRTIs, which is chronic and cumulative mitochondrial toxicity (MT).
• To underscore the clinical significance of NRTI-induced MT as an ongoing challenge in patient management.
• To emphasize the need for further research into the mechanisms and natural history of NRTI MT.

Main Methods:

• Review of existing literature on NRTI pharmacology and toxicity.
• Analysis of clinical outcomes associated with NRTI use.
• Discussion of the implications of mitochondrial dysfunction in the context of HIV treatment.

Main Results:

• A principal toxicity of NRTIs is chronic and cumulative mitochondrial toxicity (MT) in various tissues.
• The long-term impact of NRTI-induced MT is not fully understood, except in severe cases with high morbidity and mortality.
• NRTI-induced MT represents a significant clinical problem due to its chronicity and potential severity.

Conclusions:

• NRTI-induced mitochondrial toxicity is a critical clinical issue requiring further investigation.
• Elucidating the mechanisms of NRTI MT and the natural history of mitochondrial biogenesis is essential.
• Continued research will improve the understanding and management of this important side effect in HIV patients.